Model Number 1550350-12 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Angina (1710); Cardiac Arrest (1762); Death (1802); Dyspnea (1816); Cardiac Enzyme Elevation (1838); High Blood Pressure/ Hypertension (1908); Ventricular Fibrillation (2130)
|
Event Date 01/07/2020 |
Event Type
Death
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of dyspnea, angina and hypertension are listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, there is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
|
Event Description
|
Patient id: (b)(6).It was reported that on (b)(6) 2019 the 3.5x12 mm xience sierra stent was implanted in the mid left anterior descending (lad) coronary artery.On (b)(6) 2020 the patient had chest pain and shortness of breath.The patient was re-admitted to the hospital and treated with medication.An elevation in troponin was noted.The condition was dealt with as secondary to hypertensive urgency.A coronary angiogram was not performed because of the patient's history of advanced chronic kidney disease.The condition resolved on (b)(6) 2020.On (b)(6) 2020 the patient was re-admitted to the hospital again with shortness of breath and chest pain.The condition is continuing.No additional information was received.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of ventricular fibrillation, stenosis, and death are listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use as known patient effects of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
|
Event Description
|
Patient id: (b)(6).It was reported that on 3/4/2019 the 3.5x12 mm xience sierra stent was implanted in the mid left anterior descending (lad) coronary artery.On (b)(6) 2020 the patient had chest pain and shortness of breath.The patient was re-admitted to the hospital and treated with medication.The condition was dealt with as secondary to hypertensive urgency.A coronary angiogram was not performed because of the patient's history of advanced chronic kidney disease.The condition resolved on (b)(6) 2020.On (b)(6) 2020 the patient was re-admitting again with shortness of breath and chest pain.Subsequent to the previously filed report, additional information was received that on (b)(6) 2020 the patient had unstable angina.Percutaneous coronary intervention was performed on (b)(6) 2020.On (b)(6) 2020 the patient went into ventricular fibrillation/cardiac arrest.Cardio-pulmonary resuscitation was performed and medication was administered.The patient was pronounced dead in the emergency room.No additional information was received.
|
|
Search Alerts/Recalls
|
|